| __timestamp | ACADIA Pharmaceuticals Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 22746000000 |
| Thursday, January 1, 2015 | 76369000 | 21536000000 |
| Friday, January 1, 2016 | 4406000 | 21685000000 |
| Sunday, January 1, 2017 | 13060000 | 25354000000 |
| Monday, January 1, 2018 | 18330000 | 27091000000 |
| Tuesday, January 1, 2019 | 19598000 | 27556000000 |
| Wednesday, January 1, 2020 | 20550000 | 28427000000 |
| Friday, January 1, 2021 | 19141000 | 23402000000 |
| Saturday, January 1, 2022 | 10166000 | 24596000000 |
| Sunday, January 1, 2023 | 45731000 | 26553000000 |
| Monday, January 1, 2024 | 27471000000 |
Unlocking the unknown
In the ever-evolving landscape of the pharmaceutical industry, understanding cost structures is crucial. This analysis delves into the cost of revenue for two industry players: Johnson & Johnson and ACADIA Pharmaceuticals Inc., from 2014 to 2023.
Johnson & Johnson, a titan in the sector, consistently reported a cost of revenue averaging around $24.9 billion annually. Notably, their costs peaked in 2020, reflecting a 13% increase from 2014. In contrast, ACADIA Pharmaceuticals, a smaller entity, exhibited more volatility. Their costs ranged from $4.4 million in 2016 to a high of $76.4 million in 2015, indicating a dynamic growth phase.
This decade-long comparison highlights the scale and stability of Johnson & Johnson against the agile, albeit fluctuating, financial maneuvers of ACADIA Pharmaceuticals. Such insights are invaluable for investors and industry analysts alike.
Cost of Revenue: Key Insights for Johnson & Johnson and Vertex Pharmaceuticals Incorporated
Analyzing Cost of Revenue: Johnson & Johnson and BeiGene, Ltd.
Cost of Revenue Comparison: Johnson & Johnson vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Johnson & Johnson vs Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Johnson & Johnson and Geron Corporation's Expenses
Analyzing Cost of Revenue: Johnson & Johnson and Xencor, Inc.
Cost of Revenue Comparison: Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Telix Pharmaceuticals Limited vs ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Veracyte, Inc. and ACADIA Pharmaceuticals Inc.